Literature DB >> 24939307

Effect of complement C1q expression on hepatic ischemia-reperfusion injury in rats.

Xiao-Bo Feng1, Jian-Juan Ke2, Yan Rao1, Zong-Ze Zhang1, Yan-Lin Wang1.   

Abstract

The effect of the complement C1q expression on total hepatic ischemia-reperfusion (I/R) injury in rats was investigated. Sixty healthy male Sprague Dawley (SD) rats weighing 180-200 g were randomly divided into 5 groups: sham-operation group (S group, n=12); group of I/R for 1 h (I/R 1 h group, n=12); group of I/R for 3 h (I/R 3 h group, n=12); group of I/R for 6 h (I/R 6 h group, n=12); group of I/R for 24 h (I/R 24 h group, n=12). The hepatic I/R model of rats was established, and liver tissues were obtained 1 h, 3 h, 6 h and 24 h after hepatic I/R, respectively. Furthermore, the tissues were stained using hematoxylin-eosin, and the liver injuries of rats were observed using a microscope. The malondialdehyde (MDA) level and superoxide dismutase (SOD) activity in liver tissue were determined. Real-time polymerase chain reaction (PCR) and Western blotting were used to detect the expression levels of C1q mRNA and protein, respectively. As compared with the S group, the histopathological changes in I/R 1 h-24 h groups were gradually aggravated with the extension of I/R time. As compared with the S group, SOD activity and MDA content in the I/R groups were reduced and increased respectively with the extension of I/R time (P<0.01). Furthermore, the C1q expression at mRNA and protein levels in the I/R groups (especially in the I/R 3 h group) was significantly higher than that in the S group (P<0.05). It is suggested that C1q expression may play a principal role in hepatic I/R injury, particularly at the early stage of perfusion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24939307     DOI: 10.1007/s11596-014-1291-3

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

1.  Accurate and statistically verified quantification of relative mRNA abundances using SYBR Green I and real-time RT-PCR.

Authors:  Julie H Marino; Peyton Cook; Kenton S Miller
Journal:  J Immunol Methods       Date:  2003-12       Impact factor: 2.303

Review 2.  Complement therapeutics; history and current progress.

Authors:  B Paul Morgan; Claire L Harris
Journal:  Mol Immunol       Date:  2003-09       Impact factor: 4.407

Review 3.  Complement mediators in ischemia-reperfusion injury.

Authors:  Thiruma V Arumugam; Tim Magnus; Trent M Woodruff; Lavinia M Proctor; Ian A Shiels; Stephen M Taylor
Journal:  Clin Chim Acta       Date:  2006-06-14       Impact factor: 3.786

4.  Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes.

Authors:  Gábor Széplaki; Róbert Szegedi; Kristóf Hirschberg; Tímea Gombos; Lilian Varga; István Karádi; László Entz; Zoltán Széplaki; Peter Garred; Zoltán Prohászka; George Füst
Journal:  Atherosclerosis       Date:  2008-08-14       Impact factor: 5.162

5.  Hepatic ischemia reperfusion injury: Contemporary perspectives on pathogenic mechanisms and basis for hepatoprotection-the good, bad and deadly.

Authors:  Narci C Teoh
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

6.  Effects of preoperative chemotherapy on liver function tests after hepatectomy.

Authors:  M Pocard; A Vincent-Salomon; J Girodet; R J Salmon
Journal:  Hepatogastroenterology       Date:  2001 Sep-Oct

7.  Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury.

Authors:  Haekyung Lee; Danielle J Green; Lawrence Lai; Yunfang Joan Hou; Jens C Jensenius; David Liu; Cheolho Cheong; Chae Gyu Park; Ming Zhang
Journal:  Mol Immunol       Date:  2009-12-09       Impact factor: 4.407

8.  Ethanol preconditioning reduces hepatic I/R injury by inhibiting the complement system activation.

Authors:  Zheng-Wei Ma; Xiao-Bin Feng; Shu-Guo Zheng; Ping Bie; Shu-Guang Wang; Kun Li; Yu-Jun Zhang; Jia-Hong Dong
Journal:  J Surg Res       Date:  2009-06-18       Impact factor: 2.192

9.  Experimental study of liver injury after partial hepatectomy with intermittent or continuous hepatic vascular occlusion. Differences in tolerance to ischemia between normal and cirrhotic livers.

Authors:  H Isozaki; K Okajima; M Kobayashi; H Hara; H Akimoto
Journal:  Eur Surg Res       Date:  1995       Impact factor: 1.745

10.  Effects of in vivo hepatic ischemia-reperfusion injury on the hepatobiliary disposition of rhodamine 123 and its metabolites in isolated perfused rat livers.

Authors:  Ridhi Parasrampuria; Imam H Shaik; Reza Mehvar
Journal:  J Pharm Pharm Sci       Date:  2012       Impact factor: 2.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.